Copenhagen: Novo Nordisk said on Monday that in a late-stage trial, 40.4% of children aged 6 to under 12 treated with semaglutide, the active ingredient in its blockbuster weight-loss drug Wegovy, ...
A bench of Chief Justice of India Surya Kant and Justices Joymalya Bagchi and V Mohana was hearing the plea filed by ...
The liver health-related benefits evidence extends the established evidence for Wegovy in the comprehensive management of ...
The Keralam government has transferred the quality control of medicines from KMSCL to the Drugs Control Department to enhance ...
The US FDA has placed a partial hold on Biohaven's trials for the experimental epilepsy drug BHV-7000, citing potential risks ...
The Organisation of Pharmaceutical Producers of India (OPPI) appoints Amitabh Dubey, Novartis India Country President, as its ...
Natco Pharma's board has approved raising ₹1300 crore via a rights issue. This funding will bolster their acquisition ...
A prominent shareholder at Novartis is advocating for a restructuring of the board after significant setbacks in drug trials ...
Cipla has entered a licensing agreement to market Qil2107, a biosimilar of Keytruda in the US. The partnership aims to ...
AstraZeneca's tozorakimab shows promise in reducing flare-ups of chronic obstructive pulmonary disease (COPD) by 29% to 34%, ...
Novartis' cholesterol drug pelacarsen fails to reduce heart attack and stroke risk in late-stage study, impacting investor ...
Sun Pharmaceutical Industries Ltd has launched a new wholly-owned subsidiary, Sun Pharma Global Treasury Centre IFSC Ltd, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results